Ocular Therapeutix (OCUL stock gained on positive Phase 1 results for its retinal disease candidate Axpaxli in diabetic ...

In a second trial, investigators evaluated axitinib (an oral VEGF inhibitor) in 60 patients with advanced thyroid cancer (30 papillary, 15 follicular [11 Hµrthle cell variant], 11 medullary ...

Tell your doctor right away if you develop signs of dehydration . Axitinib may cause a rash that is usually not serious. Mild to moderate skin reactions include dry skin or a mildly red/itchy rash.

Review the side-effects of Axitinib Tablets as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

According to the company, 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity ...

It uses a bioresorbable hydrogel-based formulation technology. It’s developing an axitinib intravitreal implant that is in Phase 3 trials for the treatment of wet age-related macular degeneration.

prostate cancer therapy Xtandi (enzalutamide), and Inlyta (axitinib) for kidney cancer. That shift could protect the company from some of the price-cutting measures in the Inflation Reduction Act ...

During a Case-Based Roundtable® Chandler H. Park, MD, led a discussion on the considerations physicians have when deciding on ...

During a Case-Based Roundtable® event, Moshe Ornstein, MD, MA, provided guidance on dosing and toxicity concerns in a patient ...

Pregnancy. Nursing mothers. May be potentiated by strong UGT inhibitors (eg, axitinib, vandetanib, imatinib, diclofenac); monitor. May be antagonized by ritonavir, nevirapine, or strong UGT ...

OIS Retina and ARVO meetings are being held in Seattle, WashingtonBEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to ...

About AXPAXLI™ AXPAXLI is an investigational bioresorbable, hydrogel implant incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic properties, being ...